Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07536308
What this trial is testing

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Study completedNCT05406908
What this trial is testing

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Who this might be right for
Bullous DermatosesPsoriasisCOVID-19 Vaccines
Mahidol University 109
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Testing effectiveness (Phase 2)Study completedNCT05137236
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 540
Post-approval studies (Phase 4)Study completedNCT07834073
What this trial is testing

Immunogenicity and Safety of a Single Dose of mRNA SARS-CoV-2 Vaccine in Chinese Adults With Hybrid Immunity

Who this might be right for
COVID-19SARS-CoV-2 Infection
Jiangsu Province Centers for Disease Control and Prevention 2,052
Early research (Phase 1)UnknownNCT04934111
What this trial is testing

Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19

Who this might be right for
COVID-19
MRC/UVRI and LSHTM Uganda Research Unit 42
Testing effectiveness (Phase 2)WithdrawnNCT05663086
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd.
Post-approval studies (Phase 4)UnknownNCT05075083
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

Who this might be right for
COVID-19Chronic BronchitisCOPD
China National Biotec Group Company Limited 400
Early research (Phase 1)WithdrawnNCT05167253
What this trial is testing

Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.

Who this might be right for
COVID-19
United Biomedical Inc., Asia
Not applicableStudy completedNCT06119854
What this trial is testing

Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

Who this might be right for
MisinformationVaccine HesitancyAnxiety+2 more
City University of New York, School of Public Health 1,419
Not applicableUnknownNCT05075499
What this trial is testing

Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 70
Not applicableStudy completedNCT05831787
What this trial is testing

COVID19 OutcomeS in Myeloma and the Impact of VaCcines

Who this might be right for
Multiple Myeloma
ASH Research Collaborative 201
Large-scale testing (Phase 3)Not Yet RecruitingNCT07798648
What this trial is testing

COVID-19 Vaccine(s) in Children and Adults

Who this might be right for
COVID-19 Vaccines
BioNTech SE 700
Testing effectiveness (Phase 2)Study completedNCT05886777
What this trial is testing

Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).

Who this might be right for
Healthy Participants
Pfizer 1,142
Not applicableStudy completedNCT06191211
What this trial is testing

Can Doctors Reduce COVID-19 Misinformation and Increase Vaccine Uptake in Ghana? A Cluster-randomised Controlled Trial

Who this might be right for
COVID-19
London School of Economics and Political Science 7,000
Testing effectiveness (Phase 2)UnknownNCT05043311
What this trial is testing

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Large-scale testing (Phase 3)Study completedNCT05119855
What this trial is testing

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Who this might be right for
Papillomavirus InfectionsCoronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 165
Testing effectiveness (Phase 2)UnknownNCT05542693
What this trial is testing

Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

Who this might be right for
COVID-19COVID-19 Vaccine
Azidus Brasil 300
Not applicableStudy completedNCT04941209
What this trial is testing

ImPulse™ Una Infrasound-to-ultrasound E-stethoscope

Who this might be right for
Covid19COVID-19 PneumoniaCOVID-19 Respiratory Infection+4 more
Level 42 AI, Inc. 702
Testing effectiveness (Phase 2)Study completedNCT04962906
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

Who this might be right for
COVID-19 Vaccines
Ministerio de Salud de Ciudad Autónoma de Buenos Aires 192
Next Page